Briggs Morrison - Insider Trading & Ownership

Location
C/O Syndax Pharmaceuticals, Inc., 400 Totten Pond Road, Suite 110, Waltham, MA
Summary
The estimated net worth of Briggs Morrison is at least $1.55M dollars as of September 24, 2025. Briggs Morrison is the Director of ARVINAS, INC. and owns shares of ARVINAS, INC. (ARVN) stock worth about $720K. Briggs Morrison is the Director of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $636K. Briggs Morrison is the Director of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $196K.
Signature
/s/ Christina Bailey, as attorney-in-fact for Briggs Morrison
All Insider Reports
All Insider Reports

Ownership of Briggs Morrison

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARVN ARVINAS, INC. Director $720K +$227K +46% Sep 22, 2025
SNDX Syndax Pharmaceuticals Inc Director $636K Feb 7, 2024
CRSP CRISPR Therapeutics AG Director $196K Jun 5, 2025
CARM Carisma Therapeutics Inc. Director Jun 26, 2024
RPTX Repare Therapeutics Inc. Director Jun 17, 2024
HOWL Werewolf Therapeutics, Inc. Director Jun 12, 2025

Insider Transactions Reported by Briggs Morrison:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.